Label composition: CJC-1295 · Ipamorelin
Two-Pathway Peptide Stack · 10 MG + 10 MG
$129.00
CJC-1295 + Ipamorelin pairs a GHRH analog with a growth-hormone secretagogue compound in one formulation. The combination brings two different research pathways together without promising a GH-related clinical result.
15 in stock
CJC-1295 + Ipamorelin pairs a GHRH analog with a growth-hormone secretagogue compound in one formulation. The combination brings two different research pathways together without promising a GH-related clinical result.
Understand the formulation
The selected publications explain each compound's research pathway. The cited studies are preclinical and do not establish body-composition, recovery, or other clinical outcomes for the combination.
Animal research · preclinical
A mouse study examined the long-acting GHRH analog CJC-1295 and growth-hormone/IGF-1 signaling.
PubMed (PMID 16822960)
Review authoritative source : PubMed (PMID 16822960)Laboratory and animal research · preclinical
A preclinical pharmacology study characterized ipamorelin as a selective growth-hormone secretagogue.
PubMed (PMID 9849822)
Review authoritative source : PubMed (PMID 9849822)Research references describe the cited compounds or biological context; they do not establish a guaranteed outcome for this product or formulation.
